![bleeding edge technology bleeding edge technology](https://i.ytimg.com/vi/JpuaaKf3C98/maxresdefault.jpg)
Wound-related complications, such as SSIs, use additional healthcare resource and incur avoidable costs. However, in some instances infection can result in more severe consequences requiring surgical intervention.
![bleeding edge technology bleeding edge technology](https://www.techgaming.it/wp-content/uploads/2020/04/Bleeding-Edge-5-1024x576.jpg)
The majority of superficial infections are managed with antibiotics. They do not prevent post-surgical complications. In times of increasing pressures on the NHS to improve clinical outcomes and patient experience, alongside maximising efficiency and throughput, while reducing associated costs, it’s essential that industry, clinicians and business managers work effectively together to achieve these objectives.Ĭurrent post-operative dressings are designed only to manage any symptoms resulting from an incision site or infection. The number of wounds in the community is set to rise by 10 per cent in the next five years (1), providing a growing challenge to making the most of nurses’ time.
![bleeding edge technology bleeding edge technology](https://biv.com/sites/default/files/styles/facebook/public/2017-12/iqmetrix.png)
Nigel Clancy, Market Access Lead UKI & Nordics, Wound Care (Ireland), Smith & Nephew, explains. Against this backdrop of a growing need for greater efficiency, an innovative approach is delivering better outcomes than standard care for preventing surgical site complications in high-risk patients with closed surgical incisions. Wound care, dressings and bandages could not be described as the glamorous side of medicine – but they matter, and they cost.